Decrease in blood pressure after intravenous administration of urapidil during recombinant tissue plasminogen activator thrombolysis for acute ischemic stroke-Reference-Cited by-同舟云学术

Decrease in blood pressure after intravenous administration of urapidil during recombinant tissue plasminogen activator thrombolysis for acute ischemic stroke

Published:2008-09 Issue:9 Volume:30 Page:1675-1680
ISSN:0149-2918
Container-title:Clinical Therapeutics
language:en
Short-container-title:Clinical Therapeutics

Author:

Bugnicourt Jean-Marc,Duru Cécile,Picard Candice,Godefroy Olivier

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference22 articles.

1. The predictive role of 24-hour compared to casual blood pressure levels on outcome following acute stroke;Robinson;Cerebrovasc Dis,1997

2. Blood pressure decrease during the acute phase of ischemic stroke is associated with brain injury and poor stroke outcome;Castillo;Stroke,2004

3. Guidelines for the early management of adults with ischemic stroke: A guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: The American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists [published corrections appear in Stroke. 2007;38:e38 and Stroke. 2007;38:e96];Adams;Stroke,2007

4. European Stroke Initiative;Brainin;Cerebrovasc Dis,2004

5. Should a moratorium be placed on sublingual nifedipine capsules given for hypertensive emergencies and pseudoemergencies?;Grossman;JAMA,1996

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. URAPIDIL: MODERN MEDICINE FOR THE TREATMENT OF HYPERTENSIVE CRISES;Rational Pharmacotherapy in Cardiology;2013-01-01

2. Computer - based drug design, synthesis and biological evaluation of new pyrimidinone derivatives linked to arylpiperazine and 2 '-carbethoxy-biphenylylmethyl moeities as alpha(1)-adrenoceptor antagonists and angiotensin II AT(1) receptor antagonists;PHARMAZIE;2010